Effect of Denosumab or Alendronic Acid on the Progression of Aortic Stenosis: A Double-Blind Randomized Controlled Trial
Tania Pawade(MACOM (United States)), Marc R. Dweck(University of Edinburgh), Alison Fletcher(University of Edinburgh), William D. Fraser(University of Liverpool), Jack Andrews(Edinburgh Royal Infirmary), Michelle C. Williams(University of Edinburgh), Stuart H. Ralston(Western General Hospital), Emily E Evans(University of Edinburgh), Christophe Lucatelli(University of Edinburgh), Laura Forsyth(University of Edinburgh), Timothy Cartlidge(Freeman Hospital), Mhairi Doris(MACOM (United States)), William Jenkins(British Heart Foundation), Bernard Prendergast(Universidad de Londres), Catriona Graham(University of Edinburgh), Takeshi Fujisawa(British Heart Foundation), Edwin J.R. van Beek(University of Edinburgh), David E. Newby(University of Edinburgh), Maaz Syed(University of Edinburgh), Audrey White(University of Edinburgh), Rong Bing(British Heart Foundation), Nicholas A. Boon(British Heart Foundation), Philip D Adamson(Christchurch Hospital)
Cited by 145
Related Papers
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008
|European Journal of Heart Failure|2008|3.5k
2023 ESC Guidelines for the management of endocarditis
|European Heart Journal|2023|1.6k
Common genetic determinants of vitamin D insufficiency: a genome-wide association study
|The Lancet|2010|1.5k
Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement
|European Heart Journal|2022|1.3k